| abstract |
The invention relates to a composition consisting of proteins, peptides and/or peptide constituents, a pharmaceutical product containing said composition, a method for producing said composition, and the use thereof for the prophylaxis or therapy of people and/or patients with pathogenic modifications and/or defects of cellular immunity, especially cancer, sepsis or allergic reactions, in conjunction with cytostatic therapy, chemotherapy and/or radiotherapy. |